RSM-932A
RSM-932A (TCD-717) is a specific ChoKα inhibitor with IC50s of 1 and 33 μM for human recombinant ChoKα and ChoKβ enzymes, respectively. RSM-932A acts as the “first in humans” compound targeting ChoKα. RSM-932A is potent in vitro anti-proliferative and in vivo anti-tumoral activity against human xenografts in mice, showing high efficacy with low toxicity profiles[1][2][3].
Product Specifications
CAS Number
850807-63-5
Product Name Alternative
TCD-717
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Choline Kinase
Type
Reference compound
Related Pathways
Neuronal Signaling
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/rsm-932a.html
Purity
98.44
Solubility
DMSO : 16.67 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CN(C1=C2C=CC=CC2=[N+](CC3=CC=C(C4=CC=C(C[N+]5=C6C=CC=CC6=C(N(C7=CC=C(Cl)C=C7)C)C=C5)C=C4)C=C3)C=C1)C8=CC=C(Cl)C=C8.[Br-].[Br-]
Molecular Formula
C46H38Br2Cl2N4
Molecular Weight
877.53
Precautions
H302, H315, H319, H335
References & Citations
Streptococcus pneumonia
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture and light)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Lentiviral human STRIP1 sgRNA gene knockout kit - Lentiviral human STRIP1 sgRNA gene knockout kit (25)
FITC-Linked Polyclonal Antibody to Corticotropin Releasing Factor (CRF)